Relmada Therapeutics, Inc. (RLMD)
- Previous Close
3.8600 - Open
3.7900 - Bid 3.6800 x 100
- Ask 3.7400 x 500
- Day's Range
3.6600 - 3.7950 - 52 Week Range
2.3600 - 7.2230 - Volume
85,395 - Avg. Volume
215,477 - Market Cap (intraday)
111.645M - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
-- - EPS (TTM)
-3.2800 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.88
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.
www.relmada.comRecent News: RLMD
Performance Overview: RLMD
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RLMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RLMD
Valuation Measures
Market Cap
111.64M
Enterprise Value
15.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.31
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.15
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-51.76%
Return on Equity (ttm)
-87.51%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-98.79M
Diluted EPS (ttm)
-3.2800
Balance Sheet and Cash Flow
Total Cash (mrq)
96.32M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-17.91M
Research Analysis: RLMD
Company Insights: RLMD
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: RLMD
Daily – Vickers Top Insider Picks for 04/25/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/24/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/23/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/22/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.